Is there a difference in rhythm outcome between patients undergoing first line versus second line paroxysmal atrial fibrillation ablation?
Martin ManningerJakob EbnerDavid ZweikerRaphael SieghartsleitnerBernadette MastnakEgbert BispingPeter LercherRita RiedlbauerBrigitte RotmanHelmut BrusseeDaniel ScherrPublished in: PloS one (2018)
Success of AF ablation did not differ between patients who receive ablation as first vs. second line therapy. Based on these data, a trial of AAD therapy before AF ablation may be justified in most patients with symptomatic PAF eligible for rhythm control.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- left atrial appendage
- oral anticoagulants
- patients undergoing
- direct oral anticoagulants
- heart failure
- radiofrequency ablation
- percutaneous coronary intervention
- study protocol
- stem cells
- big data
- blood pressure
- coronary artery disease
- machine learning
- smoking cessation
- replacement therapy
- placebo controlled